Canine MDCK cell lines are refractory to infection with human and mouse prions (Q39990591)

16 September 2017

title

Canine MDCK cell lines are refractory to infection with human and mouse prions (English)

1 reference

16 September 2017

0 references

8

1 reference

16 September 2017

author name string

Magdalini Polymenidou

1

1 reference

16 September 2017

Heidi Trusheim

2

1 reference

16 September 2017

Lena Stallmach

3

1 reference

16 September 2017

Rita Moos

4

1 reference

16 September 2017

Christian Julius

5

1 reference

16 September 2017

Gino Miele

6

1 reference

16 September 2017

Claudia Lenz-Bauer

7

1 reference

16 September 2017

language of work or name

English

0 references

publication date

9 April 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

26

1 reference

16 September 2017

issue

21

1 reference

16 September 2017

page(s)

2601-2614

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

The impact of influenza epidemics on hospitalizations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Influenza vaccines: recent advances in production technologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Inflexal V--the influenza vaccine with the lowest ovalbumin content.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Vaccine manufacturing: challenges and solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Established kidney cell lines of normal adult bovine and ovine origin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Serial propagation of influenza B (Lee) virus in a transmissible line of canine kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Characterization of an established line of canine kidney cells (MDCK).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Prion protein NMR structures of cats, dogs, pigs, and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

No propagation of prions in mice devoid of PrP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Prions prevent neuronal cell-line death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Anchorless prion protein results in infectious amyloid disease without clinical scrapie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Species-barrier-independent prion replication in apparently resistant species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Evidence for host-cell selection of influenza virus antigenic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Avian influenza virus (H5N1): a threat to human health.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Characterization of a porcine lung epithelial cell line suitable for influenza virus studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Fibrils from brains of cows with new cattle disease contain scrapie-associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Japan's first BSE case fuels fears elsewhere.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Identification and characterization of two bovine spongiform encephalopathy cases diagnosed in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Characterization of scrapie infection in mouse neuroblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Establishment of astrocyte cell lines from sheep genetically susceptible to scrapie

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Prion infection of muscle cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

BSE: spongiform encephalopathy found in cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

Spongiform encephalopathy in a herd of greater kudu (Tragelaphus strepsiceros): epidemiological observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.035

10.1016/J.VACCINE.2008.03.035

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference